☰

Paul E. Holtzheimer - Publications

Affiliations: 
Dartmouth College, Hanover, NH, United States 
Area:
brain stimulation, neuromodulation, neuroimaging, depression, treatment-resistant depression, transcranial magnetic stimulation, deep brain stimulation
Tree Info Grants Similar researchers PubMed Report error

91/128 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Loo C, Glozier N, Barton D, Baune BT, Mills NT, Fitzgerald P, Glue P, Sarma S, Galvez-Ortiz V, Hadzi-Pavlovic D, Alonzo A, Dong V, Martin D, Nikolin S, Mitchell PB, ... ... Holtzheimer PE, et al. Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. 223: 533-541. PMID 38108319 DOI: 10.1192/bjp.2023.79  0.329
2023 Cha J, Choi KS, Rajendra JK, McGrath CL, Riva-Posse P, Holtzheimer PE, Figee M, Kopell BH, Mayberg HS. Whole brain network effects of subcallosal cingulate deep brain stimulation for treatment-resistant depression. Molecular Psychiatry. PMID 37919403 DOI: 10.1038/s41380-023-02306-6  0.32
2023 Cha J, Rajendra JJ, McGrath C, Riva-Posse P, Holtzheimer P, Mayberg H, Choi KS. Whole Brain Network effects of subcallosal cingulate deep brain stimulation for treatment-resistant depression. Research Square. PMID 37398243 DOI: 10.21203/rs.3.rs-3025802/v1  0.32
2021 Conroy SK, Holtzheimer PE. Neuromodulation Strategies for the Treatment of Depression. The American Journal of Psychiatry. 178: 1082-1088. PMID 34855452 DOI: 10.1176/appi.ajp.2021.21101034  0.34
2021 Madore MR, Kozel FA, Williams LM, Green LC, George MS, Holtzheimer PE, Yesavage JA, Philip NS. Prefrontal Transcranial Magnetic Stimulation for Depression in US Military Veterans - A Naturalistic Cohort Study in the Veterans Health Administration. Journal of Affective Disorders. PMID 34687780 DOI: 10.1016/j.jad.2021.10.025  0.39
2020 Huckins JF, DaSilva AW, Hedlund EL, Murphy EI, Rogers C, Wang W, Obuchi M, Holtzheimer PE, Wagner DD, Campbell AT. Causal Factors of Anxiety and Depression in College Students: Longitudinal Ecological Momentary Assessment and Causal Analysis Using Peter and Clark Momentary Conditional Independence. Jmir Mental Health. 7: e16684. PMID 32519971 DOI: 10.2196/16684  0.415
2020 Riva-Posse P, Crowell AL, Wright K, Waters AC, Choi K, Garlow SJ, Holtzheimer PE, Gross RE, Mayberg HS. Rapid Antidepressant Effects of Deep Brain Stimulation and Their Relation to Surgical Protocol. Biological Psychiatry. PMID 32418613 DOI: 10.1016/J.Biopsych.2020.03.017  0.374
2020 Conroy S, Elsaid N, Wen Q, Kelley M, Ford J, Wu Y, Holtzheimer P. Structural Connectivity in Currently Medicated Treatment-Resistant vs. Treatment-Responsive Depression: A Diffusion Tensor Imaging Study Biological Psychiatry. 87: S225. DOI: 10.1016/J.Biopsych.2020.02.584  0.417
2019 Riva-Posse P, Holtzheimer PE, Mayberg HS. Cingulate-mediated depressive symptoms in neurologic disease and therapeutics. Handbook of Clinical Neurology. 166: 371-379. PMID 31731923 DOI: 10.1016/B978-0-444-64196-0.00021-2  0.486
2019 Crowell AL, Riva-Posse P, Holtzheimer PE, Garlow SJ, Kelley ME, Gross RE, Denison L, Quinn S, Mayberg HS. Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression. The American Journal of Psychiatry. appiajp201918121427. PMID 31581800 DOI: 10.1176/Appi.Ajp.2019.18121427  0.53
2019 Rooij SJHv, Holtzheimer PE. Deep Brain Stimulation for Depression: Optimism for Continued Investigation Clinical Pharmacology & Therapeutics. 106: 706-708. PMID 31509628 DOI: 10.1002/Cpt.1573  0.478
2019 Lantrip C, Delaloye S, Baird L, Dreyer-Oren S, Brady RE, Roth RM, Gunning F, Holtzheimer P. Effects of Left Versus Right Dorsolateral Prefrontal Cortex Repetitive Transcranial Magnetic Stimulation on Affective Flexibility in Healthy Women: A Pilot Study. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 32: 69-75. PMID 31205120 DOI: 10.1097/Wnn.0000000000000190  0.319
2019 Philip NS, Aiken EE, Kelley ME, Burch W, Waterman L, Holtzheimer PE. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimulation. PMID 31204205 DOI: 10.1016/J.Brs.2019.06.010  0.459
2019 Tsai J, Huang M, Wilkinson ST, Edelen C, Rosenheck RA, Holtzheimer PE. A Measure to Assess Perceptions and Knowledge About Electroconvulsive Therapy: Development and Psychometric Properties. The Journal of Ect. PMID 31192871 DOI: 10.1097/Yct.0000000000000609  0.41
2019 Huckins JF, daSilva AW, Wang R, Wang W, Hedlund EL, Murphy EI, Lopez RB, Rogers C, Holtzheimer PE, Kelley WM, Heatherton TF, Wagner DD, Haxby JV, Campbell AT. Fusing Mobile Phone Sensing and Brain Imaging to Assess Depression in College Students. Frontiers in Neuroscience. 13: 248. PMID 30949024 DOI: 10.3389/Fnins.2019.00248  0.471
2019 Holtzheimer PE. Defining Mechanisms of Transcranial Magnetic Stimulation as a Treatment for Depression Through Neuroimaging: Progress and Challenges. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 201-202. PMID 29486857 DOI: 10.1016/J.Bpsc.2018.01.011  0.511
2019 Conroy SK, Holtzheimer PE. Deep brain stimulation for treatment-resistant depression: Predicting response and optimizing treatment Personalized Medicine in Psychiatry. 17: 43-45. DOI: 10.1016/J.Pmip.2019.10.002  0.514
2019 Mayberg H, Choi KS, Rajendra J, McGrath C, Holtzheimer P. 135. Differential Early and Late Antidepressant Effects of Subcallosal Cingulate DBS Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.149  0.302
2018 Wilkinson ST, Holtzheimer PE, Gao S, Kirwin DS, Price RB. Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression. Biological Psychiatry. PMID 30528745 DOI: 10.1016/J.Biopsych.2018.09.004  0.463
2018 Kavanaugh BC, Aaronson ST, Clarke GN, Holtzheimer PE, Johnson CW, McDonald WM, Schneider MB, Carpenter LL. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation with a 2-Coil Device in Treatment-Resistant Major Depressive Disorder. The Journal of Ect. PMID 29613944 DOI: 10.1097/Yct.0000000000000494  0.482
2018 Conroy S, Malloy S, Kelley M, Pirtle M, Doucette W, Roberts D, Choi K, Mayberg H, Holtzheimer P. T153. Left Versus Right Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression Biological Psychiatry. 83: S187. DOI: 10.1016/J.Biopsych.2018.02.490  0.48
2017 Holtzheimer PE, Husain MM, Lisanby SH, Taylor SF, Whitworth LA, McClintock S, Slavin KV, Berman J, McKhann GM, Patil PG, Rittberg BR, Abosch A, Pandurangi AK, Holloway KL, Lam RW, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. The Lancet. Psychiatry. PMID 28988904 DOI: 10.1016/S2215-0366(17)30371-1  0.521
2017 Carpenter LL, Aaronson ST, Clarke GN, Holtzheimer PE, Johnson CW, McDonald WM, Stannard EL, Schneider MB. rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder. Brain Stimulation. PMID 28642024 DOI: 10.1016/J.Brs.2017.06.003  0.507
2017 Riva-Posse P, Choi KS, Holtzheimer PE, Crowell AL, Garlow SJ, Rajendra JK, McIntyre CC, Gross RE, Mayberg HS. A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Molecular Psychiatry. PMID 28397839 DOI: 10.1038/Mp.2017.59  0.441
2017 Lantrip C, Gunning FM, Flashman L, Roth RM, Holtzheimer PE. Effects of Transcranial Magnetic Stimulation on the Cognitive Control of Emotion: Potential Antidepressant Mechanisms. The Journal of Ect. PMID 28072659 DOI: 10.1097/Yct.0000000000000386  0.399
2017 Lantrip C, Delaloye S, Baird L, Oren-Dreyer S, Brady R, Roth R, Holtzheimer P. 474. Effects of Left versus Right Dorsolateral Prefrontal Cortical Transcranial Magnetic Stimulation on Affective Flexibility in Healthy Women Biological Psychiatry. 81: S193. DOI: 10.1016/J.Biopsych.2017.02.958  0.312
2017 Mayberg H, McGrath C, Rajendra J, Choi K, Posse PR, Crowell A, Holtzheimer P. 351. Early and Late Cerebral Blood Flow Effects of Subcallosal Cingulate DBS for Depression: Emerging Evidence of Stimulation Induced Plasticity Biological Psychiatry. 81: S144. DOI: 10.1016/J.Biopsych.2017.02.368  0.418
2016 Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE, George MS, Sackeim HA, Lisanby SH. Long-Term Efficacy of Repeated Daily Prefrontal Transcranial Magnetic Stimulation (TMS) In Treatmnt-Resistant Depression. Focus (American Psychiatric Publishing). 14: 277-282. PMID 31997954 DOI: 10.1176/appi.focus.140204  0.374
2016 Ryder JG, Holtzheimer PE. Deep Brain Stimulation for Depression: An Update Current Behavioral Neuroscience Reports. 3: 102-108. DOI: 10.1007/S40473-016-0073-6  0.521
2015 Filkowski MM, Mayberg HS, Holtzheimer PE. Considering Eligibility for Studies of Deep Brain Stimulation for Treatment-Resistant Depression: Insights From a Clinical Trial in Unipolar and Bipolar Depression. The Journal of Ect. PMID 26479487 DOI: 10.1097/Yct.0000000000000281  0.558
2015 Hilimire MR, Mayberg HS, Holtzheimer PE, Broadway JM, Parks NA, DeVylder JE, Corballis PM. Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression. Brain Stimulation. 8: 185-91. PMID 25499035 DOI: 10.1016/J.Brs.2014.11.010  0.419
2014 Riblet N, Larson R, Watts BV, Holtzheimer P. Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis. General Hospital Psychiatry. 36: 466-73. PMID 24950919 DOI: 10.1016/J.Genhosppsych.2014.05.010  0.416
2014 Riva-Posse P, Choi KS, Holtzheimer PE, McIntyre CC, Gross RE, Chaturvedi A, Crowell AL, Garlow SJ, Rajendra JK, Mayberg HS. Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biological Psychiatry. 76: 963-9. PMID 24832866 DOI: 10.1016/J.Biopsych.2014.03.029  0.47
2014 Moreines JL, McClintock SM, Kelley ME, Holtzheimer PE, Mayberg HS. Neuropsychological function before and after subcallosal cingulate deep brain stimulation in patients with treatment-resistant depression. Depression and Anxiety. 31: 690-8. PMID 24753183 DOI: 10.1002/da.22263  0.437
2014 Delaloye S, Holtzheimer PE. Deep brain stimulation in the treatment of depression. Dialogues in Clinical Neuroscience. 16: 83-91. PMID 24733973  0.432
2014 Wajdik C, Claypoole KH, Fawaz W, Holtzheimer PE, Neumaier J, Dunner DL, Haynor DR, Roy-Byrne P, Avery DH. No change in neuropsychological functioning after receiving repetitive transcranial magnetic stimulation treatment for major depression Journal of Ect. 30: 320-324. PMID 24625717 DOI: 10.1097/Yct.0000000000000096  0.467
2014 Karsen EF, Watts BV, Holtzheimer PE. Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder. Brain Stimulation. 7: 151-7. PMID 24486424 DOI: 10.1016/J.Brs.2013.10.006  0.419
2014 McGrath CL, Kelley ME, Dunlop BW, Holtzheimer PE, Craighead WE, Mayberg HS. Pretreatment brain states identify likely nonresponse to standard treatments for depression. Biological Psychiatry. 76: 527-35. PMID 24462230 DOI: 10.1016/J.Biopsych.2013.12.005  0.463
2014 Choi KS, Holtzheimer PE, Franco AR, Kelley ME, Dunlop BW, Hu XP, Mayberg HS. Reconciling variable findings of white matter integrity in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1332-9. PMID 24352368 DOI: 10.1038/Npp.2013.345  0.401
2014 Holtzheimer PE, Mayberg HS. CORRIGENDUM TO: Neuromodulation for treatment-resistant depression F1000 Medicine Reports. 4. DOI: 10.3410/M4-22.1  0.478
2013 McGrath CL, Kelley ME, Holtzheimer PE, Dunlop BW, Craighead WE, Franco AR, Craddock RC, Mayberg HS. Toward a neuroimaging treatment selection biomarker for major depressive disorder. Jama Psychiatry. 70: 821-9. PMID 23760393 DOI: 10.1001/Jamapsychiatry.2013.143  0.434
2013 Lujan JL, Chaturvedi A, Choi KS, Holtzheimer PE, Gross RE, Mayberg HS, McIntyre CC. Tractography-activation models applied to subcallosal cingulate deep brain stimulation. Brain Stimulation. 6: 737-9. PMID 23602025 DOI: 10.1016/J.Brs.2013.03.008  0.417
2013 Riva-Posse P, Holtzheimer PE, Garlow SJ, Mayberg HS. Practical considerations in the development and refinement of subcallosal cingulate white matter deep brain stimulation for treatment-resistant depression. World Neurosurgery. 80: S27.e25-34. PMID 23246630 DOI: 10.1016/J.Wneu.2012.11.074  0.518
2013 Johnson KA, Baig M, Ramsey D, Lisanby SH, Avery D, McDonald WM, Li X, Bernhardt ER, Haynor DR, Holtzheimer PE, Sackeim HA, George MS, Nahas Z. Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimulation. 6: 108-17. PMID 22465743 DOI: 10.1016/J.Brs.2012.02.003  0.375
2012 Holtzheimer PE, Mayberg HS. Neuromodulation for treatment-resistant depression. F1000 Medicine Reports. 4: 22. PMID 23189091 DOI: 10.3410/M4-22  0.519
2012 Fisher CE, Dunn LB, Christopher PP, Holtzheimer PE, Leykin Y, Mayberg HS, Lisanby SH, Appelbaum PS. The ethics of research on deep brain stimulation for depression: decisional capacity and therapeutic misconception. Annals of the New York Academy of Sciences. 1265: 69-79. PMID 22812719 DOI: 10.1111/J.1749-6632.2012.06596.X  0.502
2012 Kelley ME, Franco AR, Mayberg HS, Holtzheimer PE. The Illness Density Index (IDI): A longitudinal measure of treatment efficacy. Clinical Trials (London, England). 9: 596-604. PMID 22801557 DOI: 10.1177/1740774512450099  0.402
2012 Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE, George MS, Sackeim HA, Lisanby SH. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depression and Anxiety. 29: 883-90. PMID 22689290 DOI: 10.1002/Da.21967  0.431
2012 Holtzheimer PE, Kosel M, Schlaepfer T. Brain stimulation therapies for neuropsychiatric disease. Handbook of Clinical Neurology. 106: 681-95. PMID 22608652 DOI: 10.1016/B978-0-444-52002-9.00041-3  0.484
2012 Hegerl U, Holtzheimer P, Mergl R, McDonald W. The neurobiology and treatment of late-life depression. Handbook of Clinical Neurology. 106: 265-78. PMID 22608627 DOI: 10.1016/B978-0-444-52002-9.00016-4  0.466
2012 Broadway JM, Holtzheimer PE, Hilimire MR, Parks NA, Devylder JE, Mayberg HS, Corballis PM. Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1764-72. PMID 22414813 DOI: 10.1038/Npp.2012.23  0.498
2012 Holtzheimer PE, Kelley ME, Gross RE, Filkowski MM, Garlow SJ, Barrocas A, Wint D, Craighead MC, Kozarsky J, Chismar R, Moreines JL, Mewes K, Posse PR, Gutman DA, Mayberg HS. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Archives of General Psychiatry. 69: 150-8. PMID 22213770 DOI: 10.1001/Archgenpsychiatry.2011.1456  0.529
2011 Dunn LB, Holtzheimer PE, Hoop JG, Mayberg HS, Appelbaum PS. Ethical Issues in Deep Brain Stimulation Research for Treatment-Resistant Depression: Focus on Risk and Consent. Ajob Neuroscience. 2: 29-36. PMID 26229726 DOI: 10.1080/21507740.2010.533638  0.466
2011 Leykin Y, Christopher PP, Holtzheimer PE, Appelbaum PS, Mayberg HS, Lisanby SH, Dunn LB. Participants' Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception. Ajob Primary Research. 2: 33-41. PMID 26225215 DOI: 10.1080/21507716.2011.627579  0.48
2011 McDonald WM, Durkalski V, Ball ER, Holtzheimer PE, Pavlicova M, Lisanby SH, Avery D, Anderson BS, Nahas Z, Zarkowski P, Sackeim HA, George MS. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depression and Anxiety. 28: 973-80. PMID 21898711 DOI: 10.1002/Da.20885  0.339
2011 Holtzheimer PE, Mayberg HS. Deep brain stimulation for psychiatric disorders. Annual Review of Neuroscience. 34: 289-307. PMID 21692660 DOI: 10.1146/Annurev-Neuro-061010-113638  0.378
2011 Polley KH, Navarro R, Avery DH, George MS, Holtzheimer PE. 2010 Updated Avery-George-Holtzheimer Database of rTMS depression studies. Brain Stimulation. 4: 115-6. PMID 21511213 DOI: 10.1016/J.Brs.2010.09.001  0.31
2011 Moreines JL, McClintock SM, Holtzheimer PE. Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimulation. 4: 17-27. PMID 21255751 DOI: 10.1016/J.Brs.2010.01.005  0.461
2011 Holtzheimer PE, Mayberg HS. Stuck in a rut: rethinking depression and its treatment. Trends in Neurosciences. 34: 1-9. PMID 21067824 DOI: 10.1016/J.Tins.2010.10.004  0.477
2011 Leykin Y, Christopher P, Holtzheimer P, Appelbaum P, Mayberg H, Lisanby S, Dunn L. Participants' Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception Ajob Primary Research. 2: 33-41. DOI: 10.1080/21507716.2011.627579  0.399
2010 Holtzheimer PE. Advances in the Management of Treatment-Resistant Depression. Focus (American Psychiatric Publishing). 8: 488-500. PMID 25960694 DOI: 10.1176/foc.8.4.foc488  0.367
2010 Holtzheimer PE, Mayberg HS. Deep brain stimulation for treatment-resistant depression. The American Journal of Psychiatry. 167: 1437-44. PMID 21131410 DOI: 10.1176/Appi.Ajp.2010.10010141  0.479
2010 Holtzheimer PE, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, Epstein CM. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depression and Anxiety. 27: 960-3. PMID 20734360 DOI: 10.1002/da.20731  0.417
2010 Holtzheimer PE, Veitengruber J, Wang CC, Krows M, Thiede H, Wald A, Roy-Byrne P. Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment. General Hospital Psychiatry. 32: 426-32. PMID 20633748 DOI: 10.1016/J.Genhosppsych.2010.02.001  0.433
2010 George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE, Schwartz T, Sackeim HA. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry. 67: 507-16. PMID 20439832 DOI: 10.1001/Archgenpsychiatry.2010.46  0.526
2010 Holtzheimer PE. Focal neuromodulation for the treatment of depression. Biological Psychiatry. 67: 97-8. PMID 20006744 DOI: 10.1016/J.Biopsych.2009.11.012  0.501
2009 Craddock RC, Holtzheimer PE, Hu XP, Mayberg HS. Disease state prediction from resting state functional connectivity. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 62: 1619-28. PMID 19859933 DOI: 10.1002/Mrm.22159  0.341
2009 Rabins P, Appleby BS, Brandt J, DeLong MR, Dunn LB, Gabriëls L, Greenberg BD, Haber SN, Holtzheimer PE, Mari Z, Mayberg HS, McCann E, Mink SP, Rasmussen S, Schlaepfer TE, et al. Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Archives of General Psychiatry. 66: 931-7. PMID 19736349 DOI: 10.1001/Archgenpsychiatry.2009.113  0.404
2009 Herbsman T, Avery D, Ramsey D, Holtzheimer P, Wadjik C, Hardaway F, Haynor D, George MS, Nahas Z. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biological Psychiatry. 66: 509-15. PMID 19545855 DOI: 10.1016/J.Biopsych.2009.04.034  0.482
2009 Rakofsky JJ, Holtzheimer PE, Nemeroff CB. Emerging targets for antidepressant therapies. Current Opinion in Chemical Biology. 13: 291-302. PMID 19501541 DOI: 10.1016/J.Cbpa.2009.04.617  0.448
2009 James GA, Kelley ME, Craddock RC, Holtzheimer PE, Dunlop BW, Nemeroff CB, Mayberg HS, Hu XP. Exploratory structural equation modeling of resting-state fMRI: applicability of group models to individual subjects. Neuroimage. 45: 778-87. PMID 19162206 DOI: 10.1016/J.Neuroimage.2008.12.049  0.326
2009 Gutman DA, Holtzheimer PE, Behrens TE, Johansen-Berg H, Mayberg HS. A tractography analysis of two deep brain stimulation white matter targets for depression. Biological Psychiatry. 65: 276-82. PMID 19013554 DOI: 10.1016/J.Biopsych.2008.09.021  0.378
2009 Holtzheimer PE. Depression as a mechanism for terminating separation distress: A critical review Neuropsychoanalysis. 11: 7-70.  0.315
2008 Holtzheimer PE, Nemeroff CB. Novel targets for antidepressant therapies. Current Psychiatry Reports. 10: 465-73. PMID 18980729 DOI: 10.1007/S11920-008-0075-5  0.409
2008 Holtzheimer PE, Meeks TW, Kelley ME, Mufti M, Young R, McWhorter K, Vito N, Chismar R, Quinn S, Dey S, Byrd EH, McDonald WM. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. International Journal of Geriatric Psychiatry. 23: 625-31. PMID 18058832 DOI: 10.1002/Gps.1951  0.43
2007 Avery DH, Holtzheimer PE, Fawaz W, Russo J, Neumaier J, Dunner DL, Haynor DR, Claypoole KH, Wajdik C, Roy-Byrne P. Transcranial magnetic stimulation reduces pain in patients with major depression: A sham-controlled study Journal of Nervous and Mental Disease. 195: 378-381. PMID 17502802 DOI: 10.1097/Nmd.0B013E31802F58D1  0.413
2006 McDonald WM, Easley K, Byrd EH, Holtzheimer P, Tuohy S, Woodard JL, Beyer K, Epstein CM. Combination rapid transcranial magnetic stimulation in treatment refractory depression. Neuropsychiatric Disease and Treatment. 2: 85-94. PMID 19412449  0.343
2006 Holtzheimer PE, Nemeroff CB. Emerging treatments for depression. Expert Opinion On Pharmacotherapy. 7: 2323-39. PMID 17109609 DOI: 10.1517/14656566.7.17.2323  0.52
2006 Holtzheimer PE, Nemeroff CB. Future prospects in depression research. Dialogues in Clinical Neuroscience. 8: 175-89. PMID 16889104  0.421
2006 McDonald WM, Holtzheimer PE, Haber M, Vitek JL, McWhorter K, Delong M. Validity of the 30-item geriatric depression scale in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1618-22. PMID 16817205 DOI: 10.1002/Mds.21023  0.404
2006 McDonald WM, Holtzheimer PE, Byrd EH. The diagnosis and treatment of depression in Parkinson's disease. Current Treatment Options in Neurology. 8: 245-55. PMID 16569383 DOI: 10.1007/S11940-006-0015-9  0.453
2006 Holtzheimer PE, Nemeroff CB. Advances in the treatment of depression. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 42-56. PMID 16490412 DOI: 10.1016/J.Nurx.2005.12.007  0.528
2006 Avery DH, Holtzheimer PE, Fawaz W, Russo J, Neumaier J, Dunner DL, Haynor DR, Claypoole KH, Wajdik C, Roy-Byrne P. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression Biological Psychiatry. 59: 187-194. PMID 16139808 DOI: 10.1016/J.Biopsych.2005.07.003  0.514
2006 Holtzheimer P. Treatment refractory depression in the elderly: A possible role for repetitive transcranial magnetic stimulation Current Psychosis & Therapeutics Reports. 4: 74-78. DOI: 10.1007/Bf02629326  0.539
2005 Holtzheimer P, Fawaz W, Wilson C, Avery D. Repetitive transcranial magnetic stimulation may induce language switching in bilingual patients. Brain and Language. 94: 274-7. PMID 16098377 DOI: 10.1016/J.Bandl.2005.01.003  0.338
2005 Srebnik DS, Rutherford LT, Peto T, Russo J, Zick E, Jaffe C, Holtzheimer P. The content and clinical utility of psychiatric advance directives Psychiatric Services. 56: 592-598. PMID 15872169 DOI: 10.1176/Appi.Ps.56.5.592  0.328
2005 Holtzheimer PE, Russo J, Zatzick D, Bundy C, Roy-Byrne PP. The impact of comorbid posttraumatic stress disorder on short-term clinical outcome in hospitalized patients with depression. The American Journal of Psychiatry. 162: 970-6. PMID 15863800 DOI: 10.1176/Appi.Ajp.162.5.970  0.366
2005 Holtzheimer PE, Avery DH. Focal brain stimulation for treatment-resistant depression: Transcranial magnetic stimulation, vagus-nerve stimulation, and deep-brain stimulation Primary Psychiatry. 12: 57-64.  0.432
2004 Holtzheimer PE, Russo J, Claypoole KH, Roy-Byrne P, Avery DH. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depression and Anxiety. 19: 24-30. PMID 14978782 DOI: 10.1002/da.10147  0.461
2003 Holtzheimer PE, Neumaier JF. Treatment of acute mania. Cns Spectrums. 8: 917-20, 924-8. PMID 14978467 DOI: 10.1017/S1092852900028698  0.316
2001 Holtzheimer PE, Russo J, Avery DH. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression Psychopharmacology Bulletin. 35: 149-169. PMID 12397863  0.44
Low-probability matches (unlikely to be authored by this person)
2018 Sippel LM, Holtzheimer PE, Friedman MJ, Schnurr PP. Defining Treatment-Resistant Posttraumatic Stress Disorder: A Framework for Future Research. Biological Psychiatry. PMID 29752073 DOI: 10.1016/J.Biopsych.2018.03.011  0.294
2021 Williams LM, Coman JT, Stetz PC, Walker NC, Kozel FA, George MS, Yoon J, Hack LM, Madore MR, Lim KO, Philip NS, Holtzheimer PE. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression. Bmc Psychiatry. 21: 35. PMID 33435926 DOI: 10.1186/s12888-020-03030-z  0.283
2010 Wingo AP, Baldessarini RJ, Holtzheimer PE, Harvey PD. Factors associated with functional recovery in bipolar disorder patients. Bipolar Disorders. 12: 319-26. PMID 20565439 DOI: 10.1111/J.1399-5618.2010.00808.X  0.273
2007 Ramasubbu R, Masalovich S, Peltier S, Holtzheimer PE, Heim C, Mayberg HS. Neural representation of maternal face processing: a functional magnetic resonance imaging study. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 52: 726-34. PMID 18399040 DOI: 10.1177/070674370705201107  0.265
2012 Craddock RC, James GA, Holtzheimer PE, Hu XP, Mayberg HS. A whole brain fMRI atlas generated via spatially constrained spectral clustering. Human Brain Mapping. 33: 1914-28. PMID 21769991 DOI: 10.1002/Hbm.21333  0.261
2010 Mufti MA, Holtzheimer PE, Epstein CM, Quinn SC, Vito N, McDonald WM. Bupropion decreases resting motor threshold: a case report. Brain Stimulation. 3: 177-80. PMID 20633447 DOI: 10.1016/J.Brs.2009.08.001  0.259
2000 Limonadi FM, Roberts DW, Darcey TM, Holtzheimer PE, Ip JT. Utilization of impedance measurements in pallidotomy using a monopolar electrode Stereotactic and Functional Neurosurgery. 72: 3-21. PMID 10640917 DOI: 10.1159/000029668  0.251
2011 Ramasubbu R, Masalovich S, Gaxiola I, Peltier S, Holtzheimer PE, Heim C, Goodyear B, Macqueen G, Mayberg HS. Differential neural activity and connectivity for processing one's own face: a preliminary report. Psychiatry Research. 194: 130-40. PMID 21962775 DOI: 10.1016/J.Pscychresns.2011.07.002  0.248
2021 van Rooij SJH, Sippel LM, McDonald WM, Holtzheimer PE. Defining focal brain stimulation targets for PTSD using neuroimaging. Depression and Anxiety. PMID 33876868 DOI: 10.1002/da.23159  0.243
2004 Holtzheimer PE, Avery D, Schlaepfer TE. Antidepressant effects of repetitive transcranial magnetic stimulation [4] British Journal of Psychiatry. 184: 541-542. PMID 15172952 DOI: 10.1192/Bjp.184.6.541-A  0.24
2023 Lantrip C, Szabo YZ, Kozel FA, Holtzheimer P. Neuromodulation as an Augmenting Strategy for Behavioral Therapies for Anxiety and PTSD: a Narrative Review. Current Treatment Options in Psychiatry. 9: 406-418. PMID 36714210  0.23
2020 Huckins JF, DaSilva AW, Wang W, Hedlund E, Rogers C, Nepal SK, Wu J, Obuchi M, Murphy EI, Meyer ML, Wagner DD, Holtzheimer PE, Campbell AT. Mental Health and Behavior During the Early Phases of the COVID-19 Pandemic: A Longitudinal Mobile Smartphone and Ecological Momentary Assessment Study in College Students. Journal of Medical Internet Research. PMID 32519963 DOI: 10.2196/20185  0.226
2004 Williams LL, Levine JB, Malhotra S, Holtzheimer P. The good-enough mentoring relationship. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association For Academic Psychiatry. 28: 111-5. PMID 15298862 DOI: 10.1176/Appi.Ap.28.2.111  0.223
2022 Visser-Vandewalle V, Andrade P, Mosley PE, Greenberg BD, Schuurman R, McLaughlin NC, Voon V, Krack P, Foote KD, Mayberg HS, Figee M, Kopell BH, Polosan M, Joyce EM, Chabardes S, ... ... Holtzheimer PE, et al. Deep brain stimulation for obsessive-compulsive disorder: a crisis of access. Nature Medicine. PMID 35840727 DOI: 10.1038/s41591-022-01879-z  0.217
2019 Almiron Bonnin DA, Holtzheimer PE, Knight J. Electroconvulsive Therapy in Recurrent Oligodendroglioma After Resection. The Journal of Ect. PMID 30973455 DOI: 10.1097/Yct.0000000000000593  0.215
1999 Holtzheimer PE, Roberts DW, Darcey TM. Magnetic resonance imaging versus computed tomography for target localization in functional stereotactic neurosurgery Neurosurgery. 45: 290-298. PMID 10449073 DOI: 10.1097/00006123-199908000-00018  0.213
2012 Christopher PP, Leykin Y, Appelbaum PS, Holtzheimer PE, Mayberg HS, Dunn LB. Enrolling in deep brain stimulation research for depression: influences on potential subjects' decision making. Depression and Anxiety. 29: 139-46. PMID 22095837 DOI: 10.1002/Da.20916  0.211
2009 Craddock R, Holtzheimer P, Hu X, Mayberg H. Disease State Prediction from Resting State FMRI Neuroimage. 47. DOI: 10.1016/S1053-8119(09)70559-2  0.21
2019 Mattocks K, Rosen MI, Sellinger J, Ngo T, Brummett B, Higgins DM, Reznik TE, Holtzheimer P, Semiatin AM, Stapley T, Martino S. Pain Care in the Department of Veterans Affairs: Understanding How a Cultural Shift in Pain Care Impacts Provider Decisions and Collaboration. Pain Medicine (Malden, Mass.). PMID 31886869 DOI: 10.1093/Pm/Pnz341  0.192
2020 Martino S, Lazar C, Sellinger J, Gilstad-Hayden K, Fenton B, Barnett PG, Brummett BR, Higgins DM, Holtzheimer P, Mattocks K, Ngo T, Reznik TE, Semiatin AM, Stapley T, Rosen MI. Screening, Brief Intervention, and Referral to Treatment for Pain Management for Veterans Seeking Service-Connection Payments for Musculoskeletal Disorders: SBIRT-PM Study Protocol. Pain Medicine (Malden, Mass.). 21: S110-S117. PMID 33313731 DOI: 10.1093/pm/pnaa334  0.128
2007 Holtzheimer PE, McDonald WM. Late-onset bipolar disorder and secondary mania Bipolar Disorder in Later Life. 53-70.  0.127
2020 Obuchi M, Huckins JF, Wang W, Dasilva A, Rogers C, Murphy E, Hedlund E, Holtzheimer P, Mirjafari S, Campbell A. Predicting Brain Functional Connectivity Using Mobile Sensing. Proceedings of the Acm On Interactive, Mobile, Wearable and Ubiquitous Technologies. 4. PMID 36540188 DOI: 10.1145/3381001  0.126
2020 Obuchi M, Huckins JF, Wang W, Dasilva A, Rogers C, Murphy E, Hedlund E, Holtzheimer P, Mirjafari S, Campbell A. Predicting Brain Functional Connectivity Using Mobile Sensing. Proceedings of the Acm On Interactive, Mobile, Wearable and Ubiquitous Technologies. 4. PMID 36540188 DOI: 10.1145/3381001  0.126
2023 Sippel LM, Khalifian CE, Knopp KC, Webster K, Maglione J, Holcomb J, Flanagan JC, Monson CM, Holtzheimer PE, Morland LA. Pilot test of intranasal oxytocin as an enhancer of brief couples therapy for posttraumatic stress disorder. Journal of Psychiatric Research. 161: 165-169. PMID 36931134 DOI: 10.1016/j.jpsychires.2023.03.001  0.118
2011 Mayberg HS, Holtzheimer PE. Targeted modulation of neural circuits: A new treatment strategy for neuropsychiatric disease Neuromethods. 54: 257-279. DOI: 10.1007/978-1-60327-202-5_11  0.116
2024 Lang AJ, Hamblen JL, Holtzheimer P, Kelly U, Norman SB, Riggs D, Schnurr PP, Wiechers I. A clinician's guide to the 2023 VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder. Journal of Traumatic Stress. PMID 38184799 DOI: 10.1002/jts.23013  0.112
2021 Sippel LM, Flanagan JC, Holtzheimer PE, Moran-Santa-Maria MM, Brady KT, Joseph JE. Effects of intranasal oxytocin on threat- and reward-related functional connectivity in men and women with and without childhood abuse-related PTSD. Psychiatry Research. Neuroimaging. 317: 111368. PMID 34455213 DOI: 10.1016/j.pscychresns.2021.111368  0.111
2024 Schnurr PP, Hamblen JL, Wolf J, Coller R, Collie C, Fuller MA, Holtzheimer PE, Kelly U, Lang AJ, McGraw K, Morganstein JC, Norman SB, Papke K, Petrakis I, Riggs D, et al. The Management of Posttraumatic Stress Disorder and Acute Stress Disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of Internal Medicine. PMID 38408360 DOI: 10.7326/M23-2757  0.104
2023 Marx BP, Hall-Clark B, Friedman MJ, Holtzheimer P, Schnurr PP. The PTSD Criterion A debate: A brief history, current status, and recommendations for moving forward. Journal of Traumatic Stress. PMID 38123526 DOI: 10.1002/jts.23007  0.101
2021 Sellinger JJ, Martino S, Lazar C, Mattocks K, Rando K, Serowik K, Ablondi K, Fenton B, Gilstad-Hayden K, Brummett B, Holtzheimer PE, Higgins D, Reznik TE, Semiatin AM, Stapley T, et al. The Acceptability and Feasibility of Screening, Brief Intervention, and Referral to Treatment for Pain Management among New England Veterans with Chronic Pain: A Pilot Study. Pain Practice : the Official Journal of World Institute of Pain. PMID 33934499 DOI: 10.1111/papr.13023  0.093
2021 Tsai J, Szymkowiak D, Wilkinson ST, Holtzheimer PE. Twenty-year trends in use of electroconvulsive therapy among homeless and domiciled veterans with mental illness. Cns Spectrums. 1-7. PMID 34895380 DOI: 10.1017/S1092852921001061  0.087
2021 Mack D, DaSilva A, Rogers C, Hedlund E, Murphy E, Vojdanovski V, Plomp J, Wang W, Nepal S, Holtzheimer P, Wagner D, Jacobson N, Meyer M, Campbell A, Huckins J. Mental Health and Behavior of College Students in the COVID-19 Pandemic : A Longitudinal Mobile Smartphone and Ecological Momentary Assessment Study- Part II. Journal of Medical Internet Research. PMID 33900935 DOI: 10.2196/28892  0.077
2011 Holtzheimer PE, Nemeroff CB. Somatic therapies Clinical Psychiatry Essentials. 443-461.  0.074
2021 Sippel LM, Holtzheimer PE, Huckins JF, Collier E, Feilong M, Wheatley T, Meyer ML. Neurocognitive mechanisms of poor social connection in posttraumatic stress disorder: Evidence for abnormalities in social working memory. Depression and Anxiety. PMID 33621379 DOI: 10.1002/da.23139  0.048
2011 Gillespie CF, Binder EB, Holtzheimer PE, Nemeroff CB. Stress and the Impact of Personalized Medicine Integrative Neuroscience and Personalized Medicine. DOI: 10.1093/acprof:oso/9780195393804.003.0005  0.036
2017 Ressler K, Holtzheimer P. Welcome. Biological Psychiatry. 81: A9. PMID 28460661 DOI: 10.1016/j.biopsych.2017.02.1094  0.01
1983 Holtzheimer PE. An introduction to the GBF/DIME: A primer Computers, Environment and Urban Systems. 8: 133-173. DOI: 10.1016/0198-9715(83)90012-1  0.01
Hide low-probability matches.